Jacobson Pharma Corporation Limited (HKG:2633)
1.270
0.00 (0.00%)
At close: Feb 13, 2026
HKG:2633 Market Cap
HKG:2633 has a market cap or net worth of 2.54 billion as of February 13, 2026. Its market cap has increased by 16.30% in one year.
Market Cap
2.54B
Enterprise Value
3.03B
Revenue
1.53B
Ranking
n/a
PE Ratio
8.36
Stock Price
1.27
Market Cap Chart
Since September 21, 2016, HKG:2633's market cap has decreased from 2.94B to 2.54B, a decrease of -13.60%. That is a compound annual growth rate of -1.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.54B | -2.31% |
| Dec 31, 2025 | 2.60B | 27.14% |
| Dec 31, 2024 | 2.05B | 67.09% |
| Dec 29, 2023 | 1.22B | -30.08% |
| Dec 30, 2022 | 1.75B | 45.06% |
| Dec 31, 2021 | 1.21B | -45.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Shineway Pharmaceutical Group | 7.50B |
| Edding Genor Group Holdings | 5.87B |
| VISEN Pharmaceuticals | 3.50B |
| Hua Medicine (Shanghai) | 3.10B |
| Essex Bio-Technology | 2.50B |
| Golden Throat Holdings Group Company | 2.35B |
| JBM (Healthcare) | 2.21B |
| Dawnrays Pharmaceutical (Holdings) | 1.77B |